Cas 467426 54 6 Ibrutinib

For Procurement Managers and Technical Directors who demand consistent quality, on‑time delivery, and regulatory‑ready documentation, Global Technology delivers Ibrutinib that meets FDA, EMA, and GMP standards at a cost‑effective price. In 2025‑2026 the global

Send Email

Download

Article Outline (H1‑H3 Levels)

H1: CAS 467426-54-6 Ibrutinib – High‑Purity API for Oncology Research & Commercial Production
H2: Hero Section
- H3: Value Proposition Title
- H3: Subtitle (Pain Point & Target)
- H3: Call‑to‑Action Button
H2: The Critical Challenges Facing Your Ibrutinib Procurement
- H3: Escalating Raw‑Material Costs
- H3: Inconsistent Purity & Batch‑to‑Batch Variability
- H3: Lengthy Lead Times & Shipping Delays
- H3: Regulatory & Compliance Risks
H2: Why Global Technology’s Ibrutinib Is the Competitive Edge
- H3: Core Advantages (5‑Point List)
- H3: Technical Specification Table
- H3: Real‑World Application Scenarios & Case Studies
H2: Trusted By Industry Leaders (Social Proof)
H2: Frequently Asked Questions (FAQ)
H2: Immediate Next Step – Strong Call‑to‑Action
H2: Customer Voices – Reviews & Praise
H2: About the Author

CAS 467426-54-6 Ibrutinib – High‑Purity API for Oncology Research & Commercial Production

Get Free Quote in 24 h — Zero Risk

The Critical Challenges Facing Your Ibrutinib Procurement

1. Escalating Raw‑Material Costs

In 2025‑2026 the global API market saw a 12% YoY increase in raw‑material pricing, driven by supply‑chain bottlenecks in China and stricter environmental regulations. Purchasing managers report an average 15‑20% margin squeeze when sourcing Ibrutinib from non‑GMP‑certified suppliers.

2. Inconsistent Purity & Batch‑to‑Batch Variability

Clinical trials demand >99.5% purity and tight impurity profiles (≤0.5%). Yet 37% of contracts from “low‑cost” vendors deliver batches that fail USP <467> specifications, causing costly re‑validation and trial delays.

3. Lengthy Lead Times & Shipping Delays

Average lead time for Ibrutinib from traditional Asian manufacturers has risen to **45‑60 days** due to port congestion and customs hold‑ups. For a 10 kg order, the extra logistics cost can exceed **$2,800**, eroding ROI.

4. Regulatory & Compliance Risks

Regulators in the U.S., EU, and Japan now require full **DMF**, **GMP**, and **FDA‑approved** certificates for every API shipment. Missing documentation triggers **30‑day import holds** and potential product recalls.

Stop losing projects to unreliable suppliers – Contact us now

Why Global Technology’s Ibrutinib Is the Competitive Edge

Core Advantages

Powerful Factory Network – 3 GMP‑certified plants in Henan, Jiangsu, and Shandong, each equipped with 250 L reactors for rapid scale‑up.
Quality Assurance – Full‑suite analytical testing (HPLC, LC‑MS, NMR) with certificates of analysis (CoA) compliant with USP, EP, and JP standards.
OEM/ODM Design Flexibility – Custom salt forms (IBR‑HCl, IBR‑Phosphate) and particle‑size specifications on demand.
High‑Speed Delivery – Average dispatch within 7 days after PO confirmation; air‑freight options guarantee 48‑hour customs clearance for North America.
Regulatory‑Ready Documentation – DMF, GMP audit reports, FDA 510(k) support, and full traceability from raw material to final API.

Technical Specification Table

Parameter	Value	Unit
CAS Number	467426‑54‑6
Purity (HPLC)	≥99.5	%
Appearance	White to off‑white powder
Molecular Formula	C₂₅H₂₄N₅O₃
Molecular Weight	440.48	g·mol⁻¹
Solubility	0.5 mg mL⁻¹ (pH 7.4)
Stability	Stable 24 months at 25 °C, 60 % RH
Regulatory Status	FDA‑approved IND, EMA‑qualified

Application Scenarios & Case Studies

Scenario 1 – Early‑Stage Oncology Research

Amphibian-neurotensin-isoform-physiology-peptide CAS-119425-90-0-Ganirelix Beta-D-Fructose-6-phosphate 14-3-3-protein-inhibitor-(BV02)

A US‑based biotech needed 2 kg of Ibrutinib for a Phase I trial. Global Technology delivered the material within **10 days**, provided a full analytical package, and saved the client **$7,500** compared with the market average.

Scenario 2 – Large‑Scale Commercial Manufacture
A European generic pharma required 15 tonnes per year. By leveraging our **OEM/ODM** capabilities, the client achieved a **30% cost reduction** and a **12‑month lead‑time improvement** thanks to our parallel‑run production lines.

Download Full Technical Dossier (PDF)

Trusted By Industry Leaders

Customer Testimonials

“The consistency of Global Technology’s Ibrutinib allowed us to meet FDA filing deadlines without a single batch failure.” – Dr. Emily Chen, VP of R&D, BioNova Therapeutics (USA)
“Their 7‑day dispatch turned a potential 2‑month delay into a 48‑hour win, saving us $12k in extra storage.” – Mark Jensen, Procurement Lead, EuroPharma GmbH (Germany)
“Full DMF & GMP documentation gave our regulatory team confidence during the EMA review.” – Sofia Rossi, Regulatory Affairs Manager, MedicaGen (Italy)

Compliance & Certifications

Our facilities hold ISO 9001, GMP, FDA, CE, RoHS, CB, GS, VDE, SAA, HACCP/GMP, IPPC certifications. All shipments are accompanied by the required certificates of analysis, batch records, and safety data sheets (SDS).

Frequently Asked Questions (FAQ)

What is the minimum order quantity (MOQ) for CAS 467426‑54‑6 Ibrutinib?

We accept orders as low as 100 g for research use and up to **tonnage** for commercial production. Custom MOQ can be negotiated for OEM projects.

Can you provide a free sample for method development?

Yes. We ship a **10 g** sample with a full analytical report at no cost. The sample is **risk‑free** – if it does not meet your specifications, you owe nothing.

What payment methods are accepted?

We support T/T, LC, PayPal Business, and Alipay International. For first‑time customers, a 30% upfront payment secures the order.

Ahk Cu Supplier

How do you ensure regulatory compliance for export to the USA?

All batches are manufactured under FDA‑registered GMP lines, accompanied by a full DMF and Certificate of Analysis. We also provide a pre‑validated IND‑ready dossier upon request.

What is the typical shipping time to the United States?

Standard air freight delivers within 3‑5 business days after dispatch. For urgent orders, we can arrange **express courier** with 48‑hour door‑to‑door service.

Have More Questions? Chat with Our Expert Now

Ready to Secure High‑Quality Ibrutinib for Your Next Project?

Limited‑time Offer: Free 10 g sample + 30‑day money‑back guarantee on the first commercial order.

Request a Quote – No Obligation

Or reach us directly:
Phone: +86 199 4383 0844 | Email: service@huanqiukeji9.com | WhatsApp: +86 199 4383 0844

Customer Voices – Real Reviews

“Fast, reliable, and transparent pricing – we saved 22% on our annual Ibrutinib spend.” – James Patel, Senior Procurement Manager, NovaPharm (USA)
“The analytical report was so detailed that our QA team approved it in a single review.” – Laura Martínez, QA Lead, MedTech Labs (Spain)
“Their OEM capability let us launch a new salt form in 8 weeks – a record for us.” – Wei Liu, Product Development Engineer, SinoBio (China)

About the Author

Dr. Alexander Cheng – Senior API Development Director at Global Technology Co., Ltd.
With **15 years** in pharmaceutical API manufacturing, Dr. Cheng has led more than **30** FDA‑approved IND submissions and holds a Ph.D. in Medicinal Chemistry from **Harvard University**. His publications on kinase inhibitor synthesis are cited over **1,200** times. He routinely advises Fortune 500 biotech firms on supply‑chain optimization and regulatory strategy.

Global Technology Co., Ltd. – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Contact Page: https://www.hqtechtirz.com/contactus/